Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-18-008385
Filing Date
2018-11-02
Accepted
2018-11-02 16:44:34
Documents
76
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q tsro-20180930x10q.htm 10-Q 1739971
2 EX-10.1 tsro-20180930ex10157dc61.htm EX-10.1 42745
3 EX-31.1 tsro-20180930ex3110b3fac.htm EX-31.1 18930
4 EX-31.2 tsro-20180930ex3129db8b3.htm EX-31.2 18923
5 EX-32.1 tsro-20180930ex3213de75a.htm EX-32.1 7248
6 EX-32.2 tsro-20180930ex322394cc4.htm EX-32.2 7438
  Complete submission text file 0001558370-18-008385.txt   7133744

Data Files

Seq Description Document Type Size
7 EX-101.INS tsro-20180930.xml EX-101.INS 1482764
8 EX-101.SCH tsro-20180930.xsd EX-101.SCH 55397
9 EX-101.CAL tsro-20180930_cal.xml EX-101.CAL 52732
10 EX-101.DEF tsro-20180930_def.xml EX-101.DEF 244127
11 EX-101.LAB tsro-20180930_lab.xml EX-101.LAB 500444
12 EX-101.PRE tsro-20180930_pre.xml EX-101.PRE 389100
Mailing Address 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451
Business Address 1000 WINTER STREET, SUITE 3300 WALTHAM MA 02451 (339) 970-0900
TESARO, Inc. (Filer) CIK: 0001491576 (see all company filings)

EIN.: 272249687 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35587 | Film No.: 181157624
SIC: 2834 Pharmaceutical Preparations